{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:21:43Z","timestamp":1776450103845,"version":"3.51.2"},"reference-count":130,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jneuroim.2006.11.026","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T07:58:33Z","timestamp":1168502313000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets"],"prefix":"10.1016","volume":"184","author":[{"given":"Orhan","family":"Aktas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Waiczies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Zipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2006.11.026_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.onc.1206206","article-title":"Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (\u2212)-epigallocatechin-3-gallate","volume":"22","author":"Afaq","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/89.24.1881","article-title":"Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells","volume":"89","author":"Ahmad","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021425","article-title":"Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin","volume":"197","author":"Aktas","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib3","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-\u03baB inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuron.2005.03.018","article-title":"Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL","volume":"46","author":"Aktas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1073858405285208","article-title":"Death ligands and autoimmune demyelination","volume":"12","author":"Aktas","year":"2006","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib8","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1073\/pnas.0530191100","article-title":"Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis","volume":"100","author":"Angelov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ana.10013","article-title":"N-acetylaspartate: usefulness as an indicator of viable neuronal tissue","volume":"50","author":"Arnold","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib11","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","article-title":"The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity","volume":"123","author":"Banati","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/NMM:7:3:217","article-title":"Failed central nervous system regeneration: a downside of immune privilege?","volume":"7","author":"Bechmann","year":"2005","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib13","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1073\/pnas.0400569101","article-title":"Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"101","author":"Benner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83\u201399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","article-title":"Acute axonal injury in multiple sclerosis:correlation with demyelination and inflammation","volume":"123","author":"Bitsch","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","article-title":"Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease","volume":"206","author":"Bjartmar","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1191\/1352458503ms917oa","article-title":"Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration","volume":"9","author":"Bo","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"Bo","year":"2003","journal-title":"J. Neuropathol. Exp Neurol"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00115-005-1963-0","article-title":"Direct neuronal effects of statins","volume":"77","author":"Bosel","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"Bosel","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002826-199106000-00010","article-title":"Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects","volume":"14","author":"Botti","year":"1991","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/73144","article-title":"p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes","volume":"6","author":"Boussiotis","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1750-3639.1996.tb00853.x","article-title":"Mechanisms of immune injury in multiple sclerosis","volume":"6","author":"Brosnan","year":"1996","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.cdd.4401143","article-title":"Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity","volume":"10","author":"Cantarella","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib26","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib27","series-title":"Lecons sur les maladies du systeme nerveux faites a la Salpetri\u00e8re","author":"Charcot","year":"1880"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.10555","article-title":"Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke","volume":"53","author":"Chen","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib31","doi-asserted-by":"crossref","first-page":"3268S","DOI":"10.1093\/jn\/133.10.3268S","article-title":"Tea and cancer prevention: studies in animals and humans","volume":"133","author":"Chung","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#","article-title":"Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis","volume":"46","author":"Coles","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib33","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M505268200","article-title":"Mechanisms of statin-mediated inhibition of small G-protein function","volume":"280","author":"Cordle","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib34","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1073\/pnas.122228799","article-title":"3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase\/ p21 signaling pathway: Implications for diabetic nephropathy","volume":"99","author":"Danesh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1017\/S0080456800027174","article-title":"The histology of disseminated sclerosis","volume":"50","author":"Dawson","year":"1916","journal-title":"Trans. R. Soc. Edinb."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awh365","article-title":"Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis","volume":"128","author":"Diem","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1084\/jem.20030975","article-title":"Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage","volume":"198","author":"Diestel","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib39","doi-asserted-by":"crossref","first-page":"RC209","DOI":"10.1523\/JNEUROSCI.22-04-j0001.2002","article-title":"Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain","volume":"22","author":"D\u00f6rr","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-5728(01)00450-7","article-title":"Induction of TRAIL-mediated glioma cell death by human T cells","volume":"122","author":"D\u00f6rr","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1043-4666(03)00094-2","article-title":"Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes","volume":"24","author":"Ehrlich","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib43","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/01.STR.0000240690.69406.28","article-title":"Discontinuation of statin treatment in stroke patients","volume":"37","author":"Endres","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1191\/1352458502ms812oa","article-title":"Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis","volume":"8","author":"Eriksson","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib45","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib47","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI23241","article-title":"Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease","volume":"115","author":"Frenkel","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis-the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib49","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm735","article-title":"Smac agonists sensitize for Apo2L\/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo","volume":"8","author":"Fulda","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mcne.2000.0904","article-title":"Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition","volume":"17","author":"Garcia-Roman","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib51","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/jimmunol.171.1.368","article-title":"Vulnerability of human neurons to T cell-mediated cytotoxicity","volume":"171","author":"Giuliani","year":"2003","journal-title":"J. Immunol."},{"issue":"Pt 8","key":"10.1016\/j.jneuroim.2006.11.026_bib52","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70\u00a0years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fj.02-1014fje","article-title":"Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis","volume":"17","author":"Greenwood","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Group THPSC","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib58","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1073\/pnas.96.8.4524","article-title":"Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea","volume":"96","author":"Haqqi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib59","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","article-title":"Translational control of p27Kip1 accumulation during the cell cycle","volume":"271","author":"Hengst","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib61","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1083\/jcb.151.7.1537","article-title":"Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration","volume":"151","author":"Heumann","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib62","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4049\/jimmunol.166.2.1314","article-title":"Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis","volume":"166","author":"Hilliard","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis","volume":"14","author":"Hobom","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/1043-4682(95)90005-5","article-title":"Control of signal transduction and morphogenesis by Ras","volume":"6","author":"Hughes","year":"1995","journal-title":"Semin. Cell. Biol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib65","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.neuroimage.2003.12.008","article-title":"Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis","volume":"21","author":"Inglese","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib66","series-title":"Current practice of clinical electroencephalography","first-page":"708","article-title":"Electrophysiology of multiple sclerosis","author":"Iragui-Madoz","year":"1990"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib67","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.256.5060.1213","article-title":"Role of CD8+ T cells in murine experimental allergic encephalomyelitis","volume":"256","author":"Jiang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib68","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib69","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/carcin\/20.11.2117","article-title":"Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (\u2212)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production","volume":"20","author":"Katiyar","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib70","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib72","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib73","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01159-9","article-title":"Protective effects of the green tea polyphenol (\u2212)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils","volume":"287","author":"Lee","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","article-title":"Mature T lymphocyte apoptosis \u2014 immune regulation in a dynamic and unpredictable antigenic environment","volume":"17","author":"Lenardo","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib76","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4644(19991001)75:1<1::AID-JCB1>3.0.CO;2-N","article-title":"Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (\u2212)-epigallocatechin-3-gallate","volume":"75","author":"Liang","year":"1999","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib78","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2005.03.021","article-title":"Mechanisms of axonal degeneration in EAE-lessons from CNTF and MHC I knockout mice","volume":"233","author":"Linker","year":"2005","journal-title":"J. Neurol Sci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib80","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.182429899","article-title":"Topical applications of caffeine or (\u2212)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice","volume":"99","author":"Lu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib81","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.168.10.4881","article-title":"Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells","volume":"168","author":"L\u00fcnemann","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.176.1.303","article-title":"Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells","volume":"176","author":"MacMicking","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib84","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1523\/JNEUROSCI.19-10-03809.1999","article-title":"CD95 ligand (Fas-L\/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons","volume":"19","author":"Martin-Villalba","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib85","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archneur.63.4.533","article-title":"Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis","volume":"63","author":"Mathiesen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1460-9568.2003.02433.x","article-title":"Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease","volume":"17","author":"Meske","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib87","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute neuronal apoptosis in a rat model of multiple sclerosis","volume":"21","author":"Meyer","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib88","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1073\/pnas.2628048100","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection","volume":"100","author":"Miura","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/toxsci\/52.suppl_1.111","article-title":"Green tea in chemoprevention of cancer","volume":"52","author":"Mukhtar","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib90","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/brain\/awg021","article-title":"Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders","volume":"126","author":"Muraro","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib91","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1074\/jbc.M004209200","article-title":"Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo","volume":"276","author":"Nam","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib92","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1212\/WNL.59.7.990","article-title":"Statins as immunomodulators: comparison with interferon-beta 1b in MS","volume":"59","author":"Neuhaus","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib93","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1474-4422(04)00770-7","article-title":"Are statins a treatment option for multiple sclerosis?","volume":"3","author":"Neuhaus","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0166-2236(02)02154-9","article-title":"Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases","volume":"25","author":"Neumann","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib95","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","article-title":"Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)","volume":"356","author":"Nitsch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib96","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1523\/JNEUROSCI.4703-03.2004","article-title":"Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue","volume":"24","author":"Nitsch","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib97","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib98","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/82107","article-title":"Immunomodulation: a new role for statins?","volume":"6","author":"Palinski","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib99","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib101","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1471-4159.2006.03763.x","article-title":"The 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons","volume":"97","author":"Pooler","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib102","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.115.3.795","article-title":"ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells","volume":"115","author":"Qiu","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib103","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: the Cardiovascular Health Study","volume":"62","author":"Rea","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib104","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.11.019","article-title":"TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia","volume":"148","author":"Ryan","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1018975928974","article-title":"In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors","volume":"11","author":"Saheki","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib107","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1471-4159.2003.02305.x","article-title":"HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis","volume":"89","author":"Schulz","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib108","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib109","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.96","article-title":"Electrically active axons degenerate when exposed to nitric oxide","volume":"49","author":"Smith","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib111","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/71548","article-title":"Autoimmune encephalomyelitis ameliorated by AMPA antagonists","volume":"6","author":"Smith","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib112","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results","volume":"62","author":"Sparks","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib113","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(99)00414-0","article-title":"Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin","volume":"269","author":"Stanislaus","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jnr.1207","article-title":"Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis","volume":"66","author":"Stanislaus","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib115","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1073\/pnas.93.6.2253","article-title":"A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry","volume":"93","author":"Steinman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib116","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1084\/jem.20030320","article-title":"Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year","volume":"197","author":"Steinman","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib117","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1383-5742(99)00059-9","article-title":"Green tea and cancer chemoprevention","volume":"428","author":"Suganuma","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib118","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/332843a0","article-title":"Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T\u2013T cell interactions","volume":"332","author":"Sun","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib119","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib120","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00001756-200403220-00002","article-title":"TRAIL is expressed in the brain cells of Alzheimer's disease patients","volume":"15","author":"Uberti","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib121","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(04)16205-3","article-title":"Oral simvastatin treatment in relapsing-remitting multiple sclerosis","volume":"363","author":"Vollmer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib122","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.4049\/jimmunol.174.9.5630","article-title":"Atorvastatin induces T cell anergy via phosphorylation of ERK1","volume":"174","author":"Waiczies","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib123","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/sita.200500058","article-title":"Modulating T cell signaling cascades by HMG-CoA reductase inhibitors","volume":"5","author":"Waiczies","year":"2005","journal-title":"Signal Transduct."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib124","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.10397","article-title":"Nitric oxide and the axonal death cascade","volume":"53","author":"Waxman","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0166-2236(86)90077-9","article-title":"Cellular immune reactivity within the CNS","volume":"9","author":"Wekerle","year":"1986","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib126","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib127","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/carcin\/19.4.611","article-title":"Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols","volume":"19","author":"Yang","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib128","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity","volume":"23","author":"Zacco","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.11.026_bib129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000073981","article-title":"Association between statin use and Alzheimer's disease","volume":"23","author":"Zamrini","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2006.11.026_bib130","doi-asserted-by":"crossref","unstructured":"Zipp, F., Aktas, O., in press. The brain as a target of inflammatory processes: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29, 518\u2013527.","DOI":"10.1016\/j.tins.2006.07.006"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806004656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806004656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:06:52Z","timestamp":1759046812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":130,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0165572806004656"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.11.026","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}